Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike
September 4, 2016
Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.
Mark Baum / Imprimis Pharmceuticals
Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.
"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.
"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."
Click Here For The Most Popular On Sunny Skyz
Couple Rescues Prairie Dog From Their Dog's Mouth, Then Decides To Adopt It
Hungry Elephant Casually Walks Into Grocery Store For Snacks In Thailand
Wild Orcas Keep Giving Humans Gifts, Leaving Experts Puzzled
My Girlfriend Gifted Me My Father’s Handwriting To Keep Forever
We Can’t Stop Looking At These Adorable Baby Loon Photos Taken On A Lake
The Funniest Dog Reactions To Hearing 'Walk' — You’ll Be Laughing Out Loud
Hero Dog Named RAMBO Scares Off Masked Robbers To Save Woman
'Am I Allowed To Be This Happy?' The Moment A Nervous Foster Dog Finally Lies In A Dog Bed
Grandma Thinks She's 60. Her Reaction To Learning She's 90 Is Priceless
Chicken Or Pigeon? The Internet Can’t Believe This Bird Is Real
